Medizinische Universität Graz - Research portal
Selected Publication:
SHR Neuro Cancer Cardio Lipid Metab Microb
Förstl, H; Bickel, H; Frölich, L; Gertz, HJ; Gutzmann, H; Hörr, R; Pantel, J; Schmidt, R; Schönknecht, P; Ulm, K; Werheid, K.
MCI-plus: mild cognitive impairment with rapid progression. Part I: prevention and therapy
Dtsch Med Wochenschr. 2009; 134(1-2): 39-44.
Doi: 10.1055/s-0028-1105890
Web of Science
PubMed
FullText
FullText_MUG
- Co-authors Med Uni Graz
- Schmidt Reinhold
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- Mild Cognitive Impairment (MCI) is a prevalent problem in the elderly and many patients show predictors of rapid cognitive decline ("MCI-plus"). MCI-plus represents a syndrome with growing importance in an ageing society, which will increasingly affect primary medicine and most other clinical specialties. We will have to face the dilemma of fast progress in the field of neurodiagnostics with innovative therapeutic strategies lagging behind. Psychological and medical co-morbidity in MCI-plus will therefore offer important opportunities to delay and to avoid the manifestation of dementia. We will review and discuss current training and treatment options including symptomatic and causal interventions.
- Find related publications in this database (using NLM MeSH Indexing)
- Aging - physiology
- Cognition Disorders - epidemiology
- Comorbidity - epidemiology
- Disease Progression - epidemiology
- Humans - epidemiology
- Risk Factors - epidemiology
- Syndrome - epidemiology
- Find related publications in this database (Keywords)
- mild cognitive impairment
- MCI-plus
- neuropsychology
- progression
- prevention
- dementia
- Alzheimer's disease
- Alzheimer phobia